ArticlePrzeglad gastroenterologiczny2026

Vedolizumab as a first-choice biological treatment of Crohn's disease in a patient with paraganglioma of the nervous system.

Patrycja Szałwińska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.